Announcements Trials

Browse Landscape

Phase

Phase 2 21 Phase 1 4 Phase NA 2 Phase 3 2 Phase 1/2 2 Phase 4 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Metformin 16 Cyclophosphamide 16 Drug Therapy 14 Dexamethasone 14 Cisplatin 13 Cytarabine 11 Gemcitabine 10 Radiotherapy 9 Oxaliplatin 9 Carboplatin 9 Vincristine 8 Paclitaxel 8 Idarubicin 8 Etoposide 8 Docetaxel 8 ulipristal acetate 7 icotinib 7 Sodium Chloride 7 Methotrexate 7 Fluorouracil 7 Dexmedetomidine 7 entecavir 6 Thalidomide 6 Surgical Procedures, Operative 6 Sorafenib 6 Pemetrexed 6 Leuprolide 6 Granulocyte Colony-Stimulating Factor 6 Epirubicin 6 Doxorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × osimertinib × Clear all

NCT05785208 2023-03-27

TEMPLE-2

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡